Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sensory neuropeptide release refers to the calcium-dependent exocytosis of neuropeptides, such as substance P, CGRP, and neurokinin A, from sensory neurons, particularly primary afferent (nociceptive) fibers, in response to various stimuli. This process plays a crucial role in modulating pain perception, inflammation, vasodilation, immune cell recruitment, and tissue repair. It is implicated in various pathophysiological conditions, including neurogenic inflammation, asthma, migraine, and chronic pain states.
Inhibition of neuropeptide release; antagonism of neuropeptide receptors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sensory Neuropeptide Release.